Notis Mc Conarty Edward Merck & Co., Inc. Transaction History

Notis Mc Conarty Edward

$202 Million
Q2 2025

A detailed history of Notis Mc Conarty Edward transactions in Merck & Co., Inc. stock. As of the latest transaction made, Notis Mc Conarty Edward holds 10,350 shares of MRK stock, worth $886,995. This represents 0.4% of its overall portfolio holdings.

Number of Shares

10,350

Previous 10,350 -0.0%

Holding current value

$886,995

Previous $929,000 11.84%

% of portfolio

0.4%

Previous 0.49%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$111.15 - $128.97 $138,937 - $161,212	-1,250 Reduced 10.78%	10,350 $1.18 Million
Q2 2024 Aug 12, 2024	SELL	$123.8 - $132.96 $173,320 - $186,144	-1,400 Reduced 10.77%	11,600 $1.44 Million
Q1 2024 Apr 29, 2024	SELL	$113.24 - $131.95 $379,354 - $442,032	-3,350 Reduced 20.49%	13,000 $1.72 Million
Q4 2023 Feb 13, 2024	SELL	$100.18 - $109.02 $155,279 - $168,981	-1,550 Reduced 8.66%	16,350 $1.78 Million
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $10,861 - $11,838	-100 Reduced 0.56%	17,900 $2.07 Million
Q1 2023 May 10, 2023	SELL	$102.94 - $114.86 $7,205 - $8,040	-70 Reduced 0.39%	18,000 $1.92 Million
Q4 2022 Feb 09, 2023	SELL	$87.44 - $112.11 $8,744 - $11,211	-100 Reduced 0.55%	18,070 $2 Million
Q3 2022 Nov 08, 2022	SELL	$84.53 - $94.96 $1,267 - $1,424	-15 Reduced 0.08%	18,170 $1.57 Million
Q1 2022 May 17, 2022	SELL	$73.51 - $82.4 $14,702 - $16,480	-200 Reduced 1.09%	18,185 $1.49 Million
Q4 2021 Feb 08, 2022	SELL	$72.28 - $90.54 $14,456 - $18,108	-200 Reduced 1.08%	18,385 $1.41 Million
Q3 2021 Nov 10, 2021	SELL	$71.68 - $78.83 $7,168 - $7,883	-100 Reduced 0.54%	18,585 $1.4 Million
Q1 2021 May 17, 2021	SELL	$68.86 - $81.11 $1,032 - $1,216	-15 Reduced 0.08%	18,685 $1.44 Million
Q4 2020 Feb 16, 2021	SELL	$71.77 - $79.65 $21,531 - $23,895	-300 Reduced 1.58%	18,700 $1.53 Million
Q3 2020 Oct 28, 2020	BUY	$73.18 - $82.95 $3,659 - $4,147	50 Added 0.26%	19,000 $1.58 Million
Q2 2020 Jul 28, 2020	SELL	$70.42 - $80.13 $17,605 - $20,032	-250 Reduced 1.3%	18,950 $1.47 Million
Q1 2020 May 07, 2020	SELL	$63.36 - $87.82 $19,008 - $26,345	-300 Reduced 1.54%	19,200 $1.48 Million
Q4 2019 Jan 15, 2020	SELL	$77.58 - $87.54 $23,274 - $26,262	-300 Reduced 1.52%	19,500 $1.77 Million
Q3 2019 Nov 04, 2019	SELL	$76.08 - $82.93 $26,628 - $29,025	-350 Reduced 1.74%	19,800 $1.67 Million
Q2 2019 Jul 24, 2019	SELL	$69.84 - $81.59 $1,746 - $2,039	-25 Reduced 0.12%	20,150 $1.69 Million
Q1 2019 Apr 29, 2019	SELL	$69.58 - $79.36 $73,059 - $83,328	-1,050 Reduced 4.95%	20,175 $1.68 Million
Q4 2018 Jan 24, 2019	SELL	$65.24 - $75.71 $49,256 - $57,161	-755 Reduced 3.43%	21,225 $1.62 Million
Q2 2018 Jul 30, 2018	SELL	$50.83 - $59.72 $12,707 - $14,930	-250 Reduced 1.12%	21,980 $1.34 Million
Q1 2018 Apr 24, 2018	SELL	$50.96 - $59.23 $30,576 - $35,538	-600 Reduced 2.63%	22,230 $1.21 Million
Q4 2017 Feb 02, 2018	BUY	$51.62 - $61.64 $201,318 - $240,396	3,900 Added 20.6%	22,830 $1.29 Million
Q3 2017 Oct 26, 2017	BUY	$58.67 - $63.13 $1.11 Million - $1.2 Million	18,930	18,930 $1.21 Million

Others Institutions Holding MRK

# of Institutions

3,842

Shares Held

1.96B

Call Options Held

29.2M

Put Options Held

30M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $217B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Notis Mc Conarty Edward, based on Form 13F filings with the SEC.

News

Stay updated on Notis Mc Conarty Edward with notifications on news.

Account

Notis Mc Conarty Edward Merck & Co., Inc. Transaction History